TVTX Latest Headlines

Travere Therapeutics (TVTX) Receives a Buy from J.P. Morgan

at www.tipranks.com (Fri, 6-Nov 9:58 AM)

Leerink Partners Sticks to Its Buy Rating for Travere Therapeutics (TVTX)

at www.tipranks.com (Thu, 5-Nov 9:31 AM)

Guggenheim Keeps Their Buy Rating on Travere Therapeutics (TVTX)

at www.tipranks.com (Wed, 4-Nov 8:55 AM)

Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS) and Travere Therapeutics (TVTX)

at www.tipranks.com (Wed, 4-Nov 4:20 AM)

Regulatory Crackdown on Cross-Border Deals Threatens Travere Therapeutics’ Partnerships, Pipeline and Long-Term Growth

at www.tipranks.com (Wed, 4-Nov 1:03 AM)

Bank of America Securities Sticks to Their Buy Rating for Travere Therapeutics (TVTX)

at www.tipranks.com (Tue, 3-Nov 9:15 AM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Inspire Medical Systems (INSP) and Travere Therapeutics (TVTX)

at www.tipranks.com (Tue, 3-Nov 8:30 AM)

Analysts Are Bullish on These Healthcare Stocks: Neurocrine (NBIX), Travere Therapeutics (TVTX)

at www.tipranks.com (Tue, 3-Nov 8:10 AM)

Travere Therapeutics (TVTX) Gets a Buy from Wells Fargo

at www.tipranks.com (Tue, 3-Nov 7:56 AM)

Travere Therapeutics Non-GAAP EPS of -$0.31 misses by $0.73, revenue of $224.5M beats by $29.21M

at seekingalpha.com (Mon, 2-Nov 4:08 PM)

Here are the major earnings after the close Monday

at seekingalpha.com (Mon, 2-Nov 9:00 AM)

Big Pharma Has $1.2 Trillion to Spend and a Revenue Gap to Fill: Inside the F/m Emerald Life Sciences Innovation ETF (LFSC)

at www.tipranks.com (Mon, 2-Nov 7:00 AM)

Travere names former Amicus CEO Bradley Campbell as next CEO in a transition slated for December 2026

Market Chameleon (Tue, 22-Sep 9:46 AM)